Delta variant already dominant in U.S., CDC estimates show | Inquirer
 
 
 
 
 
 

Delta variant already dominant in U.S., CDC estimates show

/ 09:05 AM July 07, 2021

 A man receives a coronavirus disease (COVID-19) test at a mobile testing van in Brooklyn, New York, U.S., June 2, 2021. REUTERS/Brendan McDermid

A man receives a coronavirus disease (COVID-19) test at a mobile testing van in Brooklyn, New York, U.S., June 2, 2021. REUTERS/Brendan McDermid

The Delta variant is already the dominant strain of COVID-19 in the United States, according to data modeling done by the U.S. Centers for Disease Control and Prevention (CDC).

According to the health agency’s estimates the Delta variant became dominant in the country over the two weeks ended July 3, with 51.7% cases linked to the variant that was first identified in India.

The proportion of cases linked to the Alpha variant which was first identified in Britain and had been dominant in the United States so far, fell to 28.7%.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

The data, which shows the estimated biweekly proportions of the most common SARS-CoV-2 lineages circulating in the United States, is based on sequences collected through CDC’s national genomic surveillance since Dec. 20, 2020.

The Delta variant, which is becoming dominant in many countries, is more easily transmitted than earlier versions of the coronavirus and may cause more severe disease, especially among younger people. It has now been found in every U.S. state, health officials have said.

On Tuesday, U.S. President Joe Biden encouraged Americans who have not yet been vaccinated against COVID-19 to get their shots to protect themselves from the widely spreading, highly contagious variant.

ADVERTISEMENT

So far, preliminary data has shown that vaccines made by Pfizer Inc and BioNTech, AstraZeneca and Moderna are largely protective against Delta, with the concentration of virus-neutralizing antibodies being somewhat reduced.

Want stories like this delivered straight to your inbox? Stay informed. Stay ahead. Subscribe to InqMORNING

Don't miss out on the latest news and information.
TAGS: covid, COVID-19
For feedback, complaints, or inquiries, contact us.
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.




This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.